Net Cash Flow Used in Investing Activities
Our net cash used in investing activities during the six months ended March 31, 2023, was $1,046,876, primarily due to the purchase of property and equipment of $1,046,876 compared to $0 for the six months ended March 31, 2022.
Net Cash Flow Provided by Financing Activities
Our net cash provided by financing activities during the six months ended March 31, 2023, was $341,112, a decrease of $1,732,558 or 84% from $2,073,670 for the six months ended March 31, 2022, primarily due to proceeds from non-revolving line of credit of $28,087,249 and short swing profit recovery of $1,201, offset by payments on line of credit of $27,326,600, payment of acquisition-related consideration of $250,125, issuance costs related to the uplist of our stock on the NYSE American of $86,330, deferred offering costs of $61,983, and debt issuance costs of $22,300.
Our net cash provided by financing activities for the six months ended March 31, 2022, was $2,073,670 primarily due to receipt of proceeds from credit facility of $1,500,000, proceeds from the issuance of common stock of $1,250,000, offset by the repayment on loans of $552,832 and deferred offering costs of $123,498.
As a result of the above activities, we recorded a net decrease in cash of $9,421,151 for the six months ended March 31, 2023. We reported a cash balance of $4,650,763 as of March 31, 2023.
Future Capital Requirements
We have generated limited revenue, and as of March 31, 2023, our cash totaled $4,650,763, and we had an accumulated deficit of $111,398,420. We believe that our existing cash will enable us to fund our operations for at least twelve months from the date of this Report. We have based this estimate on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we expect. We anticipate that we will continue to incur net losses for the foreseeable future; however, changing circumstances may cause us to expend cash significantly faster than we currently anticipate, and we may need to spend more cash than currently expected because of circumstances beyond our control.
Historically, our principal sources of cash have included proceeds from the issuance of common stock, preferred stock and warrants and proceeds from the issuance of debt. Our principal uses of cash have included cash used in operations, payments for license rights and payments relating to purchases of property and equipment. We expect that the principal uses of cash in the future will be for continuing operations, and general working capital requirements. We expect that as our operations continue to grow, we will need to raise additional capital to sustain operations and growth.
Non-Revolving Lines of Credit
On February 23, 2022, we entered into a Non-Revolving Line of Credit Loan Agreement (the “Prior Excel Loan Agreement”) with Excel Family Partnership, LLLP (“Excel”), an entity managed by Bruce Cassidy, Chairman of our Board of Directors, for aggregate principal amount of $1,500,000, which was amended on April 13, 2022, to increase the aggregate principal amount to $2,000,000 (the “$2m Loan”). Effective as of April 25, 2022, we entered into a Non-Revolving Line of Credit Loan Agreement with Excel (the “Excel Non-Revolving Loan Agreement”) for an aggregate principal amount of $4,022,986 (the “Excel Non-Revolving Loan”). The Excel Non-Revolving Loan matures eighteen (18) months from the date of the Excel Non-Revolving Loan Agreement and accrues interest, payable semi-annually in arrears, at a fixed rate of interest equal to twelve (12) percent per year. On April 25, 2022, we used $2,000,000 of the proceeds of the Excel Non-Revolving Loan to prepay all of the remaining outstanding principal and interest of the $2m Loan and the Prior Excel Loan Agreement was terminated in connection with such prepayment. Under the Excel Non-Revolving Loan Agreement, we granted to the lender a security interest in all of our present and future assets and properties, real or personal, tangible or intangible, wherever located, including products and proceeds thereof (which was subsequently subordinated in connection with our Revolving Loan Agreement (as defined below). In connection with the Excel Non-Revolving Loan, on April 25, 2022, we issued a warrant for an aggregate of up to 383,141 shares of our common stock. The warrant has an exercise price of $5.25 per share, expires on April 25, 2025, and shall be exercisable at any time prior to the expiration date. Effective as of December 14, 2022, we entered into a Non-Revolving Line of Credit Agreement